FDA.reportPublic FDA data

POVIDONE K30

Substance profile for UNII U725QWY32X, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Matched legacy or normalized UNII 390RMW2PEQ.

Substance Identity#

UNII
U725QWY32X
Preferred term
POVIDONE K30
Registry number
9003-39-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1297406
PubChem
0
NCIt
C82262
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1297406mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1297406
NCI ThesaurusC82262ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82262
FDA Substance Registration SystemU725QWY32Xprecision.fda.gov/uniisearch/srs/unii/U725QWY32X

Legacy UNII Aliases#

Legacy UNII, Term, Last update table
Legacy UNIITermLast update
U725QWY32XPOVIDONE K302019-03-18 19:36:14

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP for oral use Initial U.S. Approval: 20005
ATENOLOL1
ETODOLAC3
ATENOLOL1
Metformin Hydrochloride Tablets USP Rx Only3
CARISOPRODOL2
These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. ZIPRASIDONE hydrochloride capsules for oral use Initial U.S. Approval: 20013
Omeprazole DR2
TRAMADOL HYDROCHLORIDE3
Paroxetine Hydrochloride Controlled-Release Tablets1000
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
Metformin Hydrochloride Tablets USP Rx Only4
IRBESARTAN TABLETS USP 7464 7465 75141002
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
METFORMIN HYDROCHLORIDE TABLETS USP, 500 mg, 850 mg, and 1000 mg 1048 1049 7214 Rx only2
Morphine Sulfate Extended-release Capsules, USP Revised: May 2011 CII Rx only 1985282
These highlights do not include all the information needed to use Oxcarbazepine safely and effectively. See full prescribing information for Oxcarbazepine Tablets. Oxcarbazepine Tablets Initial U.S. Approval: 200014
These highlights do not include all the information needed to use meloxicam tablets USP safely and effectively. See full prescribing information for meloxicam tablets USP. MELOXICAM tablets USP for oral use Initial U.S. Approval: 20009
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19992
These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for Carvedilol Tablets, USP. Carvedilol Tablets, USP film coated for oral use Initial U.S. Approval: 199511
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
These highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
Aspirin Tablets (NSAID) * nonsteroidal anti-inflammatory drug1001
Diclofenac sodium and misoprostol delayed-release tablets3
These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951001
Imipramine Hydrochloride Tablets USP 10 mg, 25 mg and 50 mg1000
These highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 19951000
These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. Meloxicam Tablets, USP Initial U.S. Approval: 200010
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
Clarithromycin Tablets, USP R X only To reduce the development of drug-resistant bacteria and maintain the effectiveness of clarithromycin and other antibacterial drugs, clarithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.9
CITALOPRAM TABLETS USP Rx only2
Theophylline Extended-Release Tablets Rx only2
489c5c7d-75e3-4b98-b7d5-3c61e2f98adf2
LITHIUM CARBONATE Tablets USP, LITHIUM CARBONATE Capsules USP, LITHIUM Oral Solution USP2
Venlafaxine Hydrochloride Extended-Release Capsules Rx only3
6175419e-9faa-4b23-bc29-24f24e9588802
These highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
Metformin Hydrochloride Tablets USP3
These highlights do not include all the information needed to use lamotrigine tablets safely and effectively. See full prescribing information for lamotrigine tablets. LAMOTRIGINE tablets for oral use Initial U.S. Approval: 199410
Alprazolam Tablets, USP CIV2
These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP Initial U.S. Approval: 20002
TRANDOLAPRIL TABLETS 7325 7326 7327 Rx only4
Sulindac Tablets USP, 150 mg and 200 mg Rx only1
Citalopram Tablets2
Atovaquone and Proguanil Hydrochloride Tablets1
These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19991
These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 20013
Advanced AM/PM Tablet & Capsule3
Taron TM Bc2
These highlights do not include all the information needed to use Meloxicam Tablets, USP safely and effectively. See full prescribing information for Meloxicam Tablets, USP. MELOXICAM Tablets, USP Initial U.S. Approval: 20002
a1741a0b-3d4c-42dc-880d-a06e96cce9ef2
LITHIUM CARBONATE Tablets USP LITHIUM CARBONATE Capsules USP LITHIUM Oral Solution USP13
Trinatal Ultra Tablets2
Haloperidol Tablets, USP2
Drug Facts3
These highlights do not include all the information needed to use Pramipexole Dihydrochloride Tablets safely and effectively. See full prescribing information for pramipexole dihydrochloride tablets. Pramipexole Dihydrochloride Tablets for oral administration Initial U.S. Approval: 19972
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
Drug Facts1
These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951000
These highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19912
DRUG FACTS1
Aspirin Tablets (NSAID) * nonsteroidal anti-inflammatory drug3
These highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19951
These highlights do not include all the information needed to use irbesartan and hydrochlorothiazide tablets USP safely and effectively. See full prescribing information for irbesartan and hydrochlorothiazide tablets USP. IRBESARTAN and HYDROCHLOROTHIAZIDE tablets USP for oral use Initial U.S. Approval: 19974
Imipramine Hydrochloride Tablets USP1
Carisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19594
Drug Facts3
These highlights do not include all the information needed to use Tramadol Hydrochloride Extended-Release safely and effectively. See full prescribing information for Tramadol Hydrochloride Extended-Release. Tramadol Hydrochloride Extended-Release (tramadol hydrochloride) Extended-Release Capsules Initial U.S. Approval: 19952
Drug Facts5
Unknown Title2
PHOSPHA 250™ NEUTRAL Supplies 250 mg of phosphorus per tablet2
d54a97d5-3664-4ca5-bffd-8366c7255b738
Metformin Hydrochloride Tablets USP Rx Only2
SKIN DEFENSE MAKEUP SPF-152
FACE PROTECTOR SPF 403
These highlights do not include all the information needed to use levetiracetam safely and effectively. See full prescribing information for levetiracetam. Levetiracetam Tablets, USP Initial U.S. Approval: 19997
Drug Facts2
Glycopyrrolate Tablets, USP Rx Only Revised 02/114
These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19951
Mefloquine Hydrochloride Tablets Rev. 07/111
These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19593
These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19953
ARTHROTEC ® (diclofenac sodium/misoprostol) Tablets5
TRICARE PRENATAL2
BENAZEPRIL HYDROCHLORIDE TABLETS USP, 5 mg, 10 mg, 20 mg and 40 mg 5124 5125 5126 5127 Rx only3
Alprazolam Tablets, USP CIV2
Drug Facts3
Sertraline Hydrochloride Tablets Rx Only Rev. 09/113
Sertraline Hydrochloride Tablets Rx Only Rev. 09/112
Senophylline8
These highlights do not include all the information needed to use carvedilol safely and effectively. See full prescribing information for carvedilol tablets, USP. Carvedilol Tablets, USP Initial U.S. Approval: 19952
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval6
7591bed3-77ef-4074-a86f-7dcbd8070ec62
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval7
INVIRASE ® (saquinavir mesylate) CAPSULES and TABLETS3
Sertraline Hydrochloride Tablets2
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use anastrozole tablets safely and effectively. See full prescribing information for anastrozole tablets. Initial U.S. Approval2
CHLOROQUINE PHOSPHATE TABLETS, USP 250 MG and 500 MG2
P LAX TABLETS DR, 5 mg-SUGAR COATED: PINK1
Y LAX TABLETS DR, 5 mg-SUGAR COATED: YELLOW1
LITHIUM CARBONATE Tablets USP, LITHIUM CARBONATE Capsules USP, LITHIUM Oral Solution USP2
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS4
TAMOXIFEN CITRATE TABLETS USP, 10 mg and 20 mg (base) 0784 0782 Rx only2
These highlights do not include all the information needed to use lamotrigine tablets safely and effectively. See full prescribing information for Lamotrigine Tablets. Initial U.S. Approval: 19944
ETHAMBUTOL HYDROCHLORIDE TABLETS, USP3
Buprenorphine hydrochloride 8mg1002
Nifedipine Capsules2
GLIMEPIRIDE TABLET [MICRO LABS LIMITED]91224
CARISOPRODOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3970
SERTRALINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3958
ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3866
SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3832
ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3585
VENLAFAXINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3320
MELOXICAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3280
FLECTOR (DICLOFENAC EPOLAMINE ) PATCH [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3142
SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) TABLET [BRYANT RANCH PREPACK]1004
TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1002
DICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK]1001

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII U725QWY32X page 1 of 1 · 40 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POVIDONE K30U725QWY32X9003398TABLETBUCCAL1 mg
POVIDONE K30U725QWY32X9003398INJECTIONINTRAMUSCULAR0.59 %w/v
POVIDONE K30U725QWY32X9003398SOLUTIONOPHTHALMIC42 mg
POVIDONE K30U725QWY32X9003398SOLUTION/ DROPSOPHTHALMIC4 mg
POVIDONE K30U725QWY32X9003398SUSPENSIONOPHTHALMIC14 mg
POVIDONE K30U725QWY32X9003398CAPSULEORAL540 mg
POVIDONE K30U725QWY32X9003398CAPSULE, COATED, EXTENDED RELEASEORAL15 mg
POVIDONE K30U725QWY32X9003398CAPSULE, DELAYED RELEASEORAL227 mg
POVIDONE K30U725QWY32X9003398CAPSULE, DELAYED RELEASE PELLETSORAL178 mg
POVIDONE K30U725QWY32X9003398CAPSULE, EXTENDED RELEASEORAL120 mg
POVIDONE K30U725QWY32X9003398CAPSULE, LIQUID FILLEDORAL101 mg
POVIDONE K30U725QWY32X9003398GRANULEORAL202 mg
POVIDONE K30U725QWY32X9003398GRANULE, EFFERVESCENTORAL40 mg
POVIDONE K30U725QWY32X9003398GRANULE, FOR SUSPENSIONORAL120 mg
POVIDONE K30U725QWY32X9003398LOZENGEORAL700 mg
POVIDONE K30U725QWY32X9003398PELLETORAL24 mg
POVIDONE K30U725QWY32X9003398POWDERORAL378 mg
POVIDONE K30U725QWY32X9003398POWDER, FOR SOLUTIONORAL2832 mg
POVIDONE K30U725QWY32X9003398POWDER, FOR SUSPENSIONORAL257 mg
POVIDONE K30U725QWY32X9003398SOLUTIONORAL300 mg
POVIDONE K30U725QWY32X9003398SUSPENSIONORAL148 mg
POVIDONE K30U725QWY32X9003398SUSPENSION, EXTENDED RELEASEORAL474 mg
POVIDONE K30U725QWY32X9003398TABLETORAL2828 mg
POVIDONE K30U725QWY32X9003398TABLET, CHEWABLEORAL245 mg
POVIDONE K30U725QWY32X9003398TABLET, CHEWABLE, EXTENDED RELEASEORAL12 mg
POVIDONE K30U725QWY32X9003398TABLET, COATEDORAL160 mg
POVIDONE K30U725QWY32X9003398TABLET, DELAYED RELEASEORAL516 mg
POVIDONE K30U725QWY32X9003398TABLET, DELAYED RELEASE PARTICLESORAL70 mg
POVIDONE K30U725QWY32X9003398TABLET, EXTENDED RELEASEORAL368 mg
POVIDONE K30U725QWY32X9003398TABLET, FILM COATEDORAL245 mg
POVIDONE K30U725QWY32X9003398TABLET, FILM COATED, EXTENDED RELEASEORAL45 mg
POVIDONE K30U725QWY32X9003398TABLET, FOR SUSPENSIONORAL462 mg
POVIDONE K30U725QWY32X9003398TABLET, ORALLY DISINTEGRATINGORAL71 mg
POVIDONE K30U725QWY32X9003398TROCHEORAL175 mg
POVIDONE K30U725QWY32X9003398FILMSUBLINGUAL7 mg
POVIDONE K30U725QWY32X9003398TABLETSUBLINGUAL30 mg
POVIDONE K30U725QWY32X9003398AEROSOL, FOAMTOPICAL1.9 %w/w
POVIDONE K30U725QWY32X9003398FILM, EXTENDED RELEASETRANSDERMAL16 mg
POVIDONE K30U725QWY32X9003398SYSTEMTRANSDERMAL15 mg
POVIDONE K30U725QWY32X9003398INSERTVAGINAL147 mg